Trials / Withdrawn
WithdrawnNCT01053052
Study of FemVue(TM) Sono Tubal Evaluation System Method Comparison to HSG
A Comparative Study of Methods for Tubal Patency Determination and Uterine Cavity Evaluation: Sonography With the FemVue(TM) Catheter System vs. Hysterosalpingography (HSG)
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Femasys Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Multi-center prospective comparison of fallopian tubal patency determination and uterine evaluation interventions using legally marketed devices for their intended purposes, and using each subject as their own control.
Detailed description
Study cancelled prior to recruitment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sonography with FemVue, and HSG | Sono HSG for FDA 510(k) cleared indication for use |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2013-01-01
- Completion
- 2013-01-01
- First posted
- 2010-01-21
- Last updated
- 2017-05-09
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01053052. Inclusion in this directory is not an endorsement.